News

Keya medical's plaque analysis and FFR-CT reports generated from a single CT scan.

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Pi-Cardia ShortCut TAVR device

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut? 

Roderick Tung explains cardio-neuro ablation therapy for recurrent vasovagal syncope

The procedure is designed to help patients who experience frequent fainting episodes that impair their quality of life.

Medicare Advantage

"These high costs could pose barriers to care for such plans’ beneficiaries,” researchers wrote July 1 in the American Journal of Roentgenology

cybersecurity cyberattack hack hackers lock protection

The feds cautioned that exploitation of these vulnerabilities could allow attackers to write files, access unauthorized information, or crash client servers. 

Stravitz Sanyal Institute for Liver Disease and Metabolic Health at VCU

The Stravitz Sanyal Institute for Liver Disease and Metabolic Health at VCU seeks to develop new treatments that could help the millions of individuals impacted by these ailments. 

surgeon

With Election Day only four months away, healthcare is again emerging as a major source of idealistic campaign promises. Many of these are driven by widespread public angst. What sorts of changes can U.S. healthcare stakeholders realistically expect once the results are in? 

Thumbnail

Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.

The WhiteSwell eLym catheter-based device for lymphatic drainage in acute decompensated heart failure (ADHF) patients.

This new catheter-based device for lymphatic drainage showed early potential to be an effective treatment option for acute decompensated heart failure.

Marty Makary MD

Food and Drug Administration Commissioner Marty Makary is about to become a former FDA chief. The departure comes as no surprise since President Donald Trump OK’d a plan to fire him last week. 

SCAI is inviting younger female interventional cardiologists and fellows within five years of training to participate in the WONDER (Women Exposed to Occupational Doses of Radiation) study.

Concerns about radiation are believed to be a major reason so few women pursue a career in interventional cardiology. Are they right to be worried? SCAI hopes its new analysis can shed some light on this topic. 

Around the web

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut?